Quinolone and cephalosporin resistance in enteric Fever

Malini Rajinder Capoor1, Deepthi Nair

  • 1Department of Microbiology, Vardhman Mahaveer Medical College and Safdarjung Hospital, New Delhi, India.

Insights

Enteric fever treatment is challenged by widespread ciprofloxacin resistance in India. Alternative antibiotics and antimicrobial surveillance are crucial for managing this public health issue.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Enteric fever poses a significant public health threat, particularly in developing nations.
  • Ciprofloxacin resistance is now prevalent in the Indian subcontinent, complicating treatment options.
  • The irrational use of ciprofloxacin contributes to the rise of resistant strains, including nalidixic acid-resistant ones.

Purpose of the Study:

  • To review the current landscape of antimicrobial resistance in enteric fever.
  • To explore the molecular mechanisms underlying fluoroquinolone resistance.
  • To discuss novel therapeutic agents and strategies for managing ciprofloxacin-resistant enteric fever.

Main Methods:

  • This review synthesizes existing literature on enteric fever, antimicrobial resistance, and treatment strategies.
  • It examines molecular mechanisms of fluoroquinolone resistance.
  • It analyzes the efficacy and role of alternative antimicrobial agents.

Main Results:

  • Ciprofloxacin resistance is widespread, necessitating a reevaluation of first-line treatments like ampicillin, chloramphenicol, and co-trimoxazole.
  • Effective therapeutic options for ciprofloxacin-resistant enteric fever include third- and fourth-generation cephalosporins, azithromycin, tigecycline, and penems.
  • Antimicrobial surveillance and molecular analysis are vital for tracking resistance patterns and identifying new drug targets.

Conclusions:

  • The emergence of ciprofloxacin resistance demands a shift in therapeutic approaches for enteric fever.
  • Continued antimicrobial surveillance and molecular research are essential for guiding treatment and developing new interventions.
  • A strategic rollback of older, less effective antimicrobials is recommended.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...